Zong, Y.; Miyagaki, M.; Yang, M.; Zhang, J.; Zou, Y.; Ohno-Matsui, K.; Kamoi, K.
Ophthalmic Use of Targeted Biologics in the Management of Intraocular Diseases: Current and Emerging Therapies. Antibodies 2024, 13, 86.
https://doi.org/10.3390/antib13040086
AMA Style
Zong Y, Miyagaki M, Yang M, Zhang J, Zou Y, Ohno-Matsui K, Kamoi K.
Ophthalmic Use of Targeted Biologics in the Management of Intraocular Diseases: Current and Emerging Therapies. Antibodies. 2024; 13(4):86.
https://doi.org/10.3390/antib13040086
Chicago/Turabian Style
Zong, Yuan, Miki Miyagaki, Mingming Yang, Jing Zhang, Yaru Zou, Kyoko Ohno-Matsui, and Koju Kamoi.
2024. "Ophthalmic Use of Targeted Biologics in the Management of Intraocular Diseases: Current and Emerging Therapies" Antibodies 13, no. 4: 86.
https://doi.org/10.3390/antib13040086
APA Style
Zong, Y., Miyagaki, M., Yang, M., Zhang, J., Zou, Y., Ohno-Matsui, K., & Kamoi, K.
(2024). Ophthalmic Use of Targeted Biologics in the Management of Intraocular Diseases: Current and Emerging Therapies. Antibodies, 13(4), 86.
https://doi.org/10.3390/antib13040086
